IGM Biosciences Statistics
Total Valuation
IGMS has a market cap or net worth of $377.75 million. The enterprise value is $124.59 million.
| Market Cap | 377.75M |
| Enterprise Value | 124.59M |
Important Dates
The next estimated earnings date is Thursday, August 1, 2024, after market close.
| Earnings Date | Aug 1, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
IGMS has 59.02 million shares outstanding. The number of shares has increased by 35.19% in one year.
| Shares Outstanding | 59.02M |
| Shares Change (YoY) | +35.19% |
| Shares Change (QoQ) | +0.34% |
| Owned by Insiders (%) | 34.42% |
| Owned by Institutions (%) | 68.15% |
| Float | n/a |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 179.45 |
| Forward PS | 6.67 |
| PB Ratio | 2.34 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 59.19 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 7.98, with a Debt / Equity ratio of 0.25.
| Current Ratio | 7.98 |
| Quick Ratio | n/a |
| Debt / Equity | 0.25 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -108.10% and return on invested capital (ROIC) is -125.60%.
| Return on Equity (ROE) | -108.10% |
| Return on Assets (ROA) | -54.00% |
| Return on Capital (ROIC) | -125.60% |
| Revenue Per Employee | $9,745 |
| Profits Per Employee | -$1.10M |
| Employee Count | 216 |
| Asset Turnover | 0.01 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, IGMS has paid $591,000 in taxes.
| Income Tax | 591,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -30.74% in the last 52 weeks. The beta is 0.22, so IGMS's price volatility has been lower than the market average.
| Beta (5Y) | 0.22 |
| 52-Week Price Change | -30.74% |
| 50-Day Moving Average | 8.45 |
| 200-Day Moving Average | 8.54 |
| Relative Strength Index (RSI) | 35.62 |
| Average Volume (20 Days) | 302,294 |
Short Selling Information
The latest short interest is 5.18 million, so 8.77% of the outstanding shares have been sold short.
| Short Interest | 5.18M |
| Short Previous Month | 5.14M |
| Short % of Shares Out | 8.77% |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 12.36 |
Income Statement
In the last 12 months, IGMS had revenue of $2.11 million and -$236.92 million in losses. Loss per share was -$4.28.
| Revenue | 2.11M |
| Gross Profit | 2.11M |
| Operating Income | -253.94M |
| Pretax Income | -236.33M |
| Net Income | -236.92M |
| EBITDA | -222.04M |
| EBIT | -236.33M |
| Loss Per Share | -$4.28 |
Balance Sheet
The company has $294.09 million in cash and $40.93 million in debt, giving a net cash position of $253.17 million or $4.29 per share.
| Cash & Cash Equivalents | 294.09M |
| Total Debt | 40.93M |
| Net Cash | 253.17M |
| Net Cash Per Share | $4.29 |
| Equity (Book Value) | 161.25M |
| Book Value Per Share | 2.73 |
| Working Capital | 264.82M |
Cash Flow
In the last 12 months, operating cash flow was -$183.65 million and capital expenditures -$10.93 million, giving a free cash flow of -$194.58 million.
| Operating Cash Flow | -183.65M |
| Capital Expenditures | -10.93M |
| Free Cash Flow | -194.58M |
| FCF Per Share | -$3.24 |
Margins
Gross margin is 100.00%, with operating and profit margins of -12,063.80% and -11,255.25%.
| Gross Margin | 100.00% |
| Operating Margin | -12,063.80% |
| Pretax Margin | -11,227.17% |
| Profit Margin | -11,255.25% |
| EBITDA Margin | -10,548.03% |
| EBIT Margin | -11,227.17% |
| FCF Margin | -9,243.66% |
Dividends & Yields
IGMS does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -35.19% |
| Shareholder Yield | -35.19% |
| Earnings Yield | -62.72% |
| FCF Yield | -51.51% |
Analyst Forecast
The average price target for IGMS is $17.00, which is 165.63% higher than the current price. The consensus rating is "Buy".
| Price Target | $17.00 |
| Price Target Difference | 165.63% |
| Analyst Consensus | Buy |
| Analyst Count | 8 |
| Revenue Growth Forecast (5Y) | 178.89% |
| EPS Growth Forecast (5Y) | -10.44% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
IGMS has an Altman Z-Score of -3.41 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -3.41 |
| Piotroski F-Score | 3 |